welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Duchenne Muscular Dystrophy Clinical Trial

key information

study id #: NCT01874275

condition: Duchenne Muscular Dystrophy

status: completed


The primary objective of this investigation is to assess the effectiveness of transcutaneous electrical nerve stimulation applied using VECTTOR to reduce the symptoms of Duchenne Muscular Dystrophy and reduce the impact of DMD upon the participants’ quality of life. The primary outcome measures will include: 1. increased muscle strength, 2. increased range of joint motions and 3. improved sleep parameters of ASI, N3 and REM.

intervention: VECTTOR

mechanism of action: Transcutaneous electrical nerve stimulation applied to reduce the symptoms of muscle weakness

results: https://clinicaltrials.gov/ct2/show/results/NCT01874275

last updated: November 22, 2018